Anatomical Therapeutic Chemical • G04CA03 • terazosin

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

G01 Gynecological antiinfectives and antiseptics

G02 Other gynecologicals

G03 Sex hormones and modulators of the genital system

G04 Urologicals

G04B Urologicals

G04C Drugs used in benign prostatic hypertrophy

G04CA Alpha-adrenoreceptor antagonists

G04CA01 alfuzosin Indicated for: benign prostatic hyperplasia

G04CA02 tamsulosin Indicated for: benign prostatic hyperplasia

G04CA03 terazosin Indicated for: hypertension; benign prostatic hyperplasia

G04CA04 silodosin Indicated for: benign prostatic hyperplasia

G04CA52 dutasteride + tamsulosin Indicated for: benign prostatic hyperplasia

G04CA53 solifenacin succinate + tamsulosin Indicated for: benign prostatic hyperplasia

G04CA55 doxazosin + finasteride Indicated for: hypertension

G04CAN1 doxazosin Indicated for: hypertension; benign prostatic hyperplasia

G04CB Testosterone-5-alpha reductase inhibitors

G04CX Other drugs used in benign prostatic hypertrophy

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various